• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza B viruses: not to be discounted

tetano

Editor, Senior Moderator
Future Microbiol. 2015 Sep 11. [Epub ahead of print]
[h=1]Influenza B viruses: not to be discounted.[/h] van de Sandt CE[SUP]1[/SUP], Bodewes R[SUP]1[/SUP], Rimmelzwaan GF[SUP]1,[/SUP][SUP]2[/SUP], de Vries RD[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] In contrast to influenza A viruses, which have been investigated extensively, influenza B viruses have attracted relatively little attention. However, influenza B viruses are an important cause of morbidity and mortality in the human population and full understanding of their biological and epidemiological properties is imperative to better control this important pathogen. However, some of its characteristics are still elusive and warrant investigation. Here, we review evolution, epidemiology, pathogenesis and immunity and identify gaps in our knowledge of influenza B viruses. The divergence of two antigenically distinct influenza B viruses is highlighted. The co-circulation of viruses of these two lineages necessitated the development of quadrivalent influenza vaccines, which is discussed in addition to possibilities to develop universal vaccination strategies.


[h=4]KEYWORDS:[/h] animal models; evolution; human; immunity; influenza B virus; lineages; natural hosts; pathogenesis; tropism

PMID: 26357957 [PubMed - as supplied by publisher]
 
Back
Top Bottom